SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-205703
Filing Date
2014-05-20
Accepted
2014-05-20 08:01:27
Documents
9
Period of Report
2014-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d727890d8k.htm 8-K 16456
2 EX-23.1 d727890dex231.htm EX-23.1 1395
3 EX-99.1 d727890dex991.htm EX-99.1 2094299
  Complete submission text file 0001193125-14-205703.txt   19137933

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT act-20131231.xml EX-101.INS 3236443
5 XBRL TAXONOMY EXTENSION SCHEMA act-20131231.xsd EX-101.SCH 172545
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE act-20131231_cal.xml EX-101.CAL 186300
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE act-20131231_def.xml EX-101.DEF 645358
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE act-20131231_lab.xml EX-101.LAB 1233347
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE act-20131231_pre.xml EX-101.PRE 964035
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55075 | Film No.: 14856401
SIC: 2834 Pharmaceutical Preparations